Chaperone protein P4HB predicts temozolomide response and prognosis in malignant glioma.

Sun, Stella; Kiang, Karrie Mei-Yee; Leung, Gilberto Ka-Kit

Sun, Stella; Kiang, Karrie Mei-Yee; Leung, Gilberto Ka-Kit.

Afiliação

Sun S; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR 999077, P.R. China.
Kiang KM; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR 999077, P.R. China.
Leung GK; Department of Surgery, School of Clinical Medicine, LKS Faculty of Medicine, The University of Hong Kong, Queen Mary Hospital, Hong Kong, SAR 999077, P.R. China.

Oncol Lett ; 24(2): 264, 2022 Aug.

Article em En | MEDLINE | ID: mdl-35765277

Palavras-chave

MGMT promoter methylation; endoplasmic reticulum stress; glioblastoma; glioma; prognosis; prolyl 4-hydroxylase beta polypeptide; temozolomide

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Oncol Lett Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google